Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: DRA: Canada Impact+ Research Training Awards - Doctoral

University of Toronto

$120,000.00

AI-powered data integration to identify new drug targets

EF 2025-26

Résumé
"Background Post-translational protein modifications (PTMs) are central to regulating protein function, signaling pathways, and disease mechanisms. Many approved drugs act directly on modified proteins or on enzymes that write, erase, or read these modifications. However, this knowledge is scattered across multiple resources, limiting systematic discovery of drug-repositioning or screening opportunities. This project will integrate key reference resources to enable centralized, standardized querying across pathways, proteins and drugs. Methods We will integrate complementary data sources, including Reactome for curated pathway knowledge, UniProt for protein information, and DrugBank and Open Targets for drug–target and target–disease evidence. We will implement an AI-powered suite to provide researchers with a unified conversational interface to query across resources. UniProt APIs will provide curated PTM sites and functional consequences, while cross-references will link proteins and enzymes to approved drugs. Computational workflows will prioritize PTMs that modulate pathway activity and are associated with druggable enzymes or targets, enabling mapping to existing drug libraries. Results and Impact This work will produce an integrated, queryable framework linking PTMs, biological pathways, and approved drugs. Expected outcomes include prioritized candidates for drug repurposing or screening and reusable pipelines for translational research. By harmonizing trusted resources through MCP-enabled access, the project will accelerate hypothesis generation, support precision medicine, and lower barriers to leveraging existing drugs in new biological and clinical contexts."
Programme
DRA: Canada Impact+ Research Training Awards - Doctoral
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
568220
Name
Lin Zhuohui
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Canada Impact+ Research Training Awards - Doctoral
Projecttitle
AI-powered data integration to identify new drug targets
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA: Canada Impact+ Research Training Awards - Doctoral
Keyworddelim
Computational Biology; Data Discovery; Drug Repurposing; Knowledge Representation; Llm; Protein Pathways
Abstract
"Background Post-translational protein modifications (PTMs) are central to regulating protein function, signaling pathways, and disease mechanisms. Many approved drugs act directly on modified proteins or on enzymes that write, erase, or read these modifications. However, this knowledge is scattered across multiple resources, limiting systematic discovery of drug-repositioning or screening opportunities. This project will integrate key reference resources to enable centralized, standardized querying across pathways, proteins and drugs. Methods We will integrate complementary data sources, including Reactome for curated pathway knowledge, UniProt for protein information, and DrugBank and Open Targets for drug–target and target–disease evidence. We will implement an AI-powered suite to provide researchers with a unified conversational interface to query across resources. UniProt APIs will provide curated PTM sites and functional consequences, while cross-references will link proteins and enzymes to approved drugs. Computational workflows will prioritize PTMs that modulate pathway activity and are associated with druggable enzymes or targets, enabling mapping to existing drug libraries. Results and Impact This work will produce an integrated, queryable framework linking PTMs, biological pathways, and approved drugs. Expected outcomes include prioritized candidates for drug repurposing or screening and reusable pipelines for translational research. By harmonizing trusted resources through MCP-enabled access, the project will accelerate hypothesis generation, support precision medicine, and lower barriers to leveraging existing drugs in new biological and clinical contexts."
Competitiondate
202603
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lin, Zhuohui
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~